Literature DB >> 7504424

Transmission of hepatitis A to patients with hemophilia by factor VIII concentrates treated with organic solvent and detergent to inactivate viruses. The Italian Collaborative Group.

P M Mannucci1, S Gdovin, A Gringeri, M Colombo, A Mele, N Schinaia, N Ciavarella, S U Emerson, R H Purcell.   

Abstract

OBJECTIVE: To determine whether an outbreak of hepatitis A virus (HAV) infection that occurred in 52 patients with hemophilia in Italy was acquired through infusion of contaminated factor VIII or through environmental enteric transmission.
DESIGN: A case-control study and a molecular analysis of HAV sequences from implicated lots of factor VIII and from infected patients. PATIENTS: The first 29 patients with hemophilia and jaundice in whom hepatitis A developed were compared with one to three matched controls with hemophilia but no jaundice. MEASUREMENTS: Type of concentrate and batches infused, number of doses, contacts with persons who had jaundice or hepatitis A, travel abroad to countries reported to have a high attack rate for hepatitis A, and consumption of raw shellfish. Hepatitis A viral sequences sought by polymerase chain reaction in lots of factor VIII and in serial serum samples from two patients with hemophilia in whom hepatitis A developed. Amplification by polymerase chain reaction of cDNA transcribed with reverse transcriptase from matched sets of factor VIII and recipient serum samples. Determination of nucleotide sequence of amplified hepatitis A virus genome. MAIN
RESULTS: Case patients were neither more nor less likely than controls to have traveled to high-risk countries, consumed raw shellfish, or had contact with persons with jaundice. Case patients were more likely than controls to have received a factor VIII concentrate treated with a solvent-detergent mixture to inactivate viruses (odds ratio, infinity; 95% CI, 4.5 to infinity) and to have had larger infusions of the concentrate during the presumed HAV incubation period (odds ratio, 8.54; CI, 2.78 to 27.5). Hepatitis A viral sequences were found in 5 of 12 tested lots of factor VIII. Genomic sequences of HAV obtained for two matched sets of factor VIII and recipient serum samples were identical within each set but different for the two sets.
CONCLUSION: Hepatitis A was transmitted by a factor VIII concentrate treated by a virucidal method (solvent-detergent) that ineffectively inactivates nonenveloped viruses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7504424     DOI: 10.7326/0003-4819-120-1-199401010-00001

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  19 in total

1.  Vertical transmission of hepatitis A.

Authors:  Ramesh L Renge; V S Dani; S D Chitambar; V A Arankalle
Journal:  Indian J Pediatr       Date:  2002-06       Impact factor: 1.967

2.  High cost, low volume care in haemophilia.

Authors:  J Selway
Journal:  BMJ       Date:  1998-05-02

Review 3.  Clinical development of a new inactivated hepatitis A vaccine.

Authors:  E Vidor; B Fritzell; S Plotkin
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

4.  HAV and HEV infection in hospitalised hepatitis patients in Alexandria, Egypt.

Authors:  M Divizia; R Gabrieli; M L Stefanoni; E Renganathan; E El Ghazzawi; O A Kader; F Gamil; G El Sawaf; E El Sherbini; E Saleh; A M Degener; A Noce; L Zaratti; A Modesti; A Panà
Journal:  Eur J Epidemiol       Date:  1999-08       Impact factor: 8.082

Review 5.  The History of Hepatitis A.

Authors:  Daniel Shouval
Journal:  Clin Liver Dis (Hoboken)       Date:  2020-10-07

Review 6.  Hepatitis A: old and new.

Authors:  J A Cuthbert
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

7.  Excretion of hepatitis A virus (HAV) in adults: comparison of immunologic and molecular detection methods and relationship between HAV positivity and infectivity in tamarins.

Authors:  L B Polish; B H Robertson; B Khanna; K Krawczynski; J Spelbring; F Olson; C N Shapiro
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

8.  Cross-border paid plasma donation among injection drug users in two Mexico-U.S. border cities.

Authors:  Patricia Volkow; Kimberly C Brouwer; Oralia Loza; Rebeca Ramos; Remedios Lozada; Richard S Garfein; Carlos Magis-Rodriguez; Michelle Firestone-Cruz; Steffanie A Strathdee
Journal:  Int J Drug Policy       Date:  2009-02-20

9.  Transfusion-transmitted infections in haemophilia patients.

Authors:  Bukurije Zhubi; Ymer Mekaj; Zana Baruti; Ilirijane Bunjaku; Mazllum Belegu
Journal:  Bosn J Basic Med Sci       Date:  2009-11       Impact factor: 3.363

10.  Hepatitis B in children in Italy: incidence and risk factors: SEIEVA Collaborating Group. Sistema Epidemiologico Integrato dell'Epatite virale Acuta.

Authors:  R Corona; C Gandolfi; L Ferrigno; L Sagliocca; F Ciaralli; A Martelli; C Galanti; A Moiraghi; F Palumbo; F Novaco
Journal:  Eur J Epidemiol       Date:  1994-04       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.